Evidence map›Paper›PMID 25198012›Full record

ArticleNature communications2014

Loss of Wdfy3 in mice alters cerebral cortical neurogenesis reflecting aspects of the autism pathology.

Lori A Orosco, Adam P Ross, Staci L Cates, Sean E Scott, Dennis Wu, Jiho Sohn, David Pleasure, Samuel J Pleasure, Iannis E Adamopoulos, Konstantinos S Zarbalis

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. TheiScience · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The evolving biology of cross-presentation.Seminars in immunology · 2023
    Review
  15. Article
  16. Macroautophagy in CNS health and disease.Nature reviews. Neuroscience · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Wdfy3 regulates glycophagy, mitophagy, and synaptic plasticity.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lori A Orosco1] Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, California 95817, USA [2] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
Adam P Ross1] Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, California 95817, USA [2] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
Staci L Cates1] Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, California 95817, USA [2] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
Sean E Scott1] Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, California 95817, USA [2] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
Dennis Wu1] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA [2] Department of Internal Medicine, Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, California 95616, USA.
Jiho SohnInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
David Pleasure1] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA [2] Departments of Neurology and Pediatrics, University of California at Davis, Sacramento, California 95817, USA.
Samuel J PleasureDepartment of Neurology, Programs in Neuroscience, Developmental and Stem Cell Biology, UCSF Institute for Regeneration Medicine, University of California at San Francisco, Sandler Neurosciences Center, Box 3206, 675 Nelson Rising Lane, Room 214, San Francisco, California 94158, USA.
Iannis E Adamopoulos1] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA [2] Department of Internal Medicine, Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, California 95616, USA.
Konstantinos S Zarbalis1] Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, California 95817, USA [2] Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, 2425 Stockton Boulevard, Sacramento, California 95817, USA.
Shriners Hospitals for Children - Northern California · USUniversity of California, Davis · USUniversity of California, San Francisco · US

Funding

High-throughput targeted mutagenesis of mouse stem cell linesU01HG004080 · NHGRI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DE JONG, PIETER J. · 2006 to 2010
$28.1M
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES CellsU01HG004085 · NHGRI · REGENERON PHARMACEUTICALS, INC. · PI VALENZUELA, DAVID MANUEL · 2006 to 2010
$25.3M
UCD KOMP PROJECT REPOSITORYU42RR024244 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2007 to 2010
$7.9M
Defective Forebrain Development in Mutant MiceR01MH105360 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PLEASURE, SAMUEL JEREMY · 2014 to 2015
$790k
Wdfy3, a novel regulator of neuronal migration and connectivityR21HD067855 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZARBALIS, KONSTANTINOS · 2011 to 2012
$422k
NCRR NIH HHS U42 RR024244NCRR NIH HHS U42RR024244NHGRI NIH HHS U01 HG004080NHGRI NIH HHS U01HG004080NHGRI NIH HHS U01 HG004085NHGRI NIH HHS U01HG004085NICHD NIH HHS R21 HD067855NIMH NIH HHS R01 MH105360PHS HHS NICHD R21HD67855
6 · The paper itself

Abstract

Autism spectrum disorders (ASDs) are complex and heterogeneous developmental disabilities affecting an ever-increasing number of children worldwide. The diverse manifestations and complex, largely genetic aetiology of ASDs pose a major challenge to the identification of unifying neuropathological features. Here we describe the neurodevelopmental defects in mice that carry deleterious alleles of the Wdfy3 gene, recently recognized as causative in ASDs. Loss of Wdfy3 leads to a regionally enlarged cerebral cortex resembling early brain overgrowth described in many children on the autism spectrum. In addition, affected mouse mutants display migration defects of cortical projection neurons, a recognized cause of epilepsy, which is significantly comorbid with autism. Our analysis of affected mouse mutants defines an important role for Wdfy3 in regulating neural progenitor divisions and neural migration in the developing brain. Furthermore, Wdfy3 is essential for cerebral expansion and functional organization while its loss-of-function results in pathological changes characteristic of ASDs.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutophagy-Related ProteinsCell MovementCerebral CortexChild Development Disorders, PervasiveMiceMice, TransgenicNeurogenesisVesicular Transport ProteinsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsVesicular Transport ProteinsWdfy3 protein, mouse

Identifiers

PMID25198012
PMCPMC4159772
OpenAlexW2059543801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.